Skip to main content
Clinical Trials/TCTR20210901003
TCTR20210901003
Not yet recruiting
Phase 2

A comparison of clinical outcome among undenatured collagen type II, Glucosamine sulphate and Diacerein on osteoarthritic knee treatment :A randomized controlled trial

Department Orthopaedic Surgery0 sites216 target enrollmentSeptember 1, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
This research is designed to fulfill the understanding of the clinical outcome of osteoarthritic knee treatment by Undenatured collagen type II, Glucosamine sulphate and Diacerein.
Sponsor
Department Orthopaedic Surgery
Enrollment
216
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2021
End Date
October 1, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department Orthopaedic Surgery

Eligibility Criteria

Inclusion Criteria

  • Primary knee OA based on the clinical criteria of the American College of Rheumatology
  • \-Had radiographic evidence of OA with a Kellgren and Lawrance grade of 2\-3
  • \-Had not received UC\-II or pCGS or diacerein within previous 6 months
  • \-Had pain score (NPRS) at knee more than 4

Exclusion Criteria

  • \-Had undergone knee replacement surgery
  • \-Previous intra\-articular treatment of the knee joint with any product(corticosteroids in the previous 2 months or hyaluronic acid in the previous 6months)
  • \-Gastrointestinal disease (gastroesophageal reflux disorder, inflammatory bowel syndrome, peptic ulcer, and duodenal ulcer)
  • \-Chronic kidney disease (GFR \< 30\)
  • \-Liver disease (Cirrhosis child B\-C,Hepatic failure,HCC)
  • \-Uncontrolled diabetes mellitus (HbA1C \< 7\.0\)
  • \-Allergy to Undenatured collagen type II, Glucosamine sulphate, Diacerein, Acetaminophen, Naproxen
  • \-Immobilization
  • \-Usage of warfarin

Outcomes

Primary Outcomes

Not specified

Similar Trials